Pathophysiology of Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 294 of the 297 references it cites were found in a registry or an index.
Abstract
Type 2 Diabetes Mellitus (T2DM), one of the most common metabolic disorders, is caused by a combination of two primary factors: defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond appropriately to insulin. Because insulin release and activity are essential processes for glucose homeostasis, the molecular mechanisms involved in the synthesis and release of insulin, as well as in its detection are tightly regulated. Defects in any of the mechanisms involved in these processes can lead to a metabolic imbalance responsible for the development of the disease. This review analyzes the key aspects of T2DM, as well as the molecular mechanisms and pathways implicated in insulin metabolism leading to T2DM and insulin resistance. For that purpose, we summarize the data gathered up until now, focusing especially on insulin synthesis, insulin release, insulin sensing and on the downstream effects on individual insulin-sensitive organs. The review also covers the pathological conditions perpetuating T2DM such as nutritional factors, physical activity, gut dysbiosis and metabolic memory. Additionally, because T2DM is associated with accelerated atherosclerosis development, we review here some of the molecular mechanisms that link T2DM and insulin resistance (IR) as well as cardiovascular risk as one of the most important complications in T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“T2D is considered a polygenic condition with considerable heterogeneity in degrees of insulin deficiency and resistance and accounts for >90% of all cases of DM.32”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“Likewise, diabetes is secondary to altered glucose homeostasis [67], and this study suggests a critical role for NHE3 in the regulation of SGLT1, which is the predominant intestinal glucose transporter.”
From Regulation of Enterocyte Brush Border Membrane Primary Na-Absorptive Transporters in Human Intestinal Organoid-Derived Monolayers (2024) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–294 of 294
Early Atherosclerosis in Obese Juveniles Is Associated with Low Serum Levels of Adiponectin
Pilz, S., Horejsi, R., Möller, R., Almer, G., Scharnagl, H., Stojakovic, T., Dimitrova, R., Weihrauch, G., Borkenstein, M., Maerz, W., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0167 · Cited by 179
Margetic, S. (2012) · Biochemia Medica · doi:10.11613/bm.2012.006 · Cited by 177 · cited 1×
“These pro-inflammatory cytokines stimulate the expression and release of pro-coagulant molecules and inhibit the expression of anti-coagulant molecules by endothelial cells [245].”
BackgroundHDL dysfunction in diabetes: causes and possible treatments
Farbstein, D., & Levy, A. P. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.182 · Cited by 174 · cited 1×
“In addition, within the milieu of IR of diabetes, HDL particle concentrations are not only quantitatively reduced, but also tend to be dysfunctional and unable to perform their primary functions, including reversal of cholesterol transport and inhibition of oxidative and inflammatory phenomena [232].”
BackgroundType 2 diabetes: genetic data sharing to advance complex disease research
Flannick, J. A., & Florez, J. C. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.56 · Cited by 173 · cited 1×
“According to these data, the genetic architecture of T2DM is highly polygenic, and additional association studies are needed to identify most T2DM loci [24].”
BackgroundHyperglycemia Activates Caspase-1 and TXNIP-Mediated IL-1β Transcription in Human Adipose Tissue
Koenen, T. B., Stienstra, R., van Tits, L. J., de Graaf, J., Stalenhoef, A. F. H., Joosten, L. A. B., Tack, C. J., & Netea, M. G. (2011) · Diabetes · doi:10.2337/db10-0266 · Cited by 172
Epigenetics and Epigenomics: Implications for Diabetes and Obesity
Rosen, E. D., Kaestner, K. H., Natarajan, R., Patti, M.-E., Sallari, R., Sander, M., & Susztak, K. (2018) · Diabetes · doi:10.2337/db18-0537 · Cited by 171 · cited 1×
“Disruptions or imbalances in epigenetic mechanisms can lead to the development of diabetic pathophysiology [90].”
BackgroundThe emerging challenge in diabetes: The “metabolic memory”
Ceriello, A. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.05.005 · Cited by 170 · cited 2×
“It also activates PKC isoforms and upregulates the hexosamine pathway contributing to T2DM worsening [129,130].”
BackgroundThe Beta Cell in Type 2 Diabetes
Christensen, A. A., & Gannon, M. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1196-4 · Cited by 163 · cited 3×
“Under these circumstances, β-cells, due to differences in their genetic susceptibility, are subject to toxic pressures including inflammation, inflammatory stress, ER stress, metabolic/oxidative stress, amyloid stress, with the potential of ultimately leading to a loss of islet integrity [50].”
BackgroundInfluentialMishra, S. (2013) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2013/6518.3306 · Cited by 160
MicroRNAs as stress regulators in pancreatic beta cells and diabetes
LaPierre, M. P., & Stoffel, M. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.020 · Cited by 158 · cited 1×
“Increasing evidence highlights the importance of miRNA mediated post-transcriptional regulation in different aspects of β-cell biology such as cell differentiation, cytokine and growth factor-mediated signaling, glucose metabolism and insulin synthesis and secretion [92].”
BackgroundCohn, J. S., Marcoux, C., & Davignon, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2474 · Cited by 156 · cited 1×
“TRLs are highly heterogeneous in size, density, and apolipoprotein composition [198].”
BackgroundMargetić, S. (2012) · PubMed Central · Cited by 155
Gene-Environment and Gene-Treatment Interactions in Type 2 Diabetes
Franks, P. W., Pearson, E., & Florez, J. C. (2013) · Diabetes Care · doi:10.2337/dc12-2211 · Cited by 154 · cited 1×
“Interactions between susceptibility loci and environmental factors could underlie the missing heritability of T2DM thus the impact of a given genetic variant can be modulated by the environmental factors (and vice versa) as evidenced by both observational studies and clinical trials [25].”
BackgroundWong, N. D., Zhao, Y., Patel, R., Patao, C., Malik, S., Bertoni, A. G., Correa, A., Folsom, A. R., Kachroo, S., Mukherjee, J., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2439 · Cited by 151 · cited 1×
“People of different ethnic origins may have different specific phenotypes that increase predisposition to clusters of CVD risk factors, including hypertension, insulin resistance, and dyslipidemia [11].”
BackgroundThe many secret lives of adipocytes: implications for diabetes
Scherer, P. E. (2019) · Diabetologia · doi:10.1007/s00125-018-4777-x · Cited by 151 · cited 2×
“with pathologic vascularisation, hypoxia, fibrosis and macrophage-mediated inflammation [167].”
BackgroundMcNamara, J. R., Small, D. M., Li, Z., & Schaefer, E. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37557-x · Cited by 147
Lionetti, L., Mollica, M. P., Donizzetti, I., Gifuni, G., Sica, R., Pignalosa, A., Cavaliere, G., Gaita, M., De Filippo, C., Zorzano, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092753 · Cited by 144 · cited 1×
“Fusion-shifted mitochondria dynamics has been also associated with an increase in fatty acid utilization putatively preventing lipotoxicity [145].”
BackgroundBernelot Moens, S. J., Verweij, S. L., Schnitzler, J. G., Stiekema, L. C. A., Bos, M., Langsted, A., Kuijk, C., Bekkering, S., Voermans, C., Verberne, H. J., et al. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.308834 · Cited by 144 · cited 2×
“cholesterol deposition and inflammation as a result of TRLs entry into the artery wall [196,197].”
BackgroundVascular Effects of Novel Adipocytokines: Focus on Vascular Contractility and Inflammatory Responses
Yamawaki, H. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.307 · Cited by 142 · cited 1×
“Several studies indicate that adipokines are related to IR, and can result in endothelial dysfunction, and pro-inflammatory and pro-atherogenic states [258,259].”
BackgroundSatoh, T. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151018677 · Cited by 140 · cited 1×
“This process allows glucose uptake and reduces circulating glucose levels [159].”
BackgroundOlsen, A. S., Sarras, M. P., Leontovich, A. A., & Intine, R. V. A. (2012) · Diabetes · doi:10.2337/db11-0588 · Cited by 139
Caligiuri, A., Bertolani, C., Guerra, C. T., Aleffi, S., Galastri, S., Trappoliere, M., Vizzutti, F., Gelmini, S., Laffi, G., Pinzani, M., et al. (2008) · Hepatology · doi:10.1002/hep.21995 · Cited by 136 · cited 1×
“In addition, adiponectin ameliorates β-cell death by neutralizing inflammatory and lipotoxic ceramides and DAGs [264] and shows strong anti-inflammatory effects on other cell types such as macrophages and fibrogenic cells [263,265,266].”
BackgroundAdipocyte Modulation of High-Density Lipoprotein Cholesterol
Zhang, Y., McGillicuddy, F. C., Hinkle, C. C., O'Neill, S., Glick, J. M., Rothblat, G. H., & Reilly, M. P. (2010) · Circulation · doi:10.1161/circulationaha.109.897330 · Cited by 135
Varbo, A., Freiberg, J. J., & Nordestgaard, B. G. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.279463 · Cited by 133
Type 1 and Type 2 Diabetes in Asian and Pacific Islander U.S. Youth
Liu, L. L., Yi, J. P., Beyer, J., Mayer-Davis, E. J., Dolan, L. M., Dabelea, D. M., Lawrence, J. M., Rodriguez, B. L., Marcovina, S. M., Waitzfelder, B. E., et al. (2009) · Diabetes Care · doi:10.2337/dc09-s205 · Cited by 130
Dimova, R. B., & Tankova, T. I. (2015) · BioMed Research International · doi:10.1155/2015/823481 · Cited by 127 · cited 1×
“Vaspin (visceral adipose tissue-derived serine protease inhibitor) is an adipokine that inhibits proteases responsible for IR and protects against atherosclerosis and plaque development [284,285].”
Background3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s003 · Cited by 124
Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocyte-macrophages.
Van Lenten, B. J., Fogelman, A. M., Jackson, R. L., Shapiro, S., Haberland, M. E., & Edwards, P. A. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39420-6 · Cited by 122 · cited 7×
“In an effort to offload TG from remnant lipoproteins (VLDL 2+3 and IDL; RLPs), CETP is activated and promotes an exchange of TG out of RLPs and incorporates CE from HDL and LDL particles [213].”
BackgroundInfluentialObesity and Metabolic Syndrome: An Inflammatory Condition
Scarpellini, E., & Tack, J. (2012) · Digestive Diseases · doi:10.1159/000336664 · Cited by 122
Latreille, M., Herrmanns, K., Renwick, N., Tuschl, T., Malecki, M. T., McCarthy, M. I., Owen, K. R., Rülicke, T., & Stoffel, M. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1296-9 · Cited by 122
The physiological and molecular regulation of lipoprotein assembly and secretion
Blasiole, D. A., Davis, R. A., & Attie, A. D. (2007) · Molecular BioSystems · doi:10.1039/b700706j · Cited by 120 · cited 2×
“Indeed, IR leads to a loss of the acute insulin-mediated inhibition of apoB100 secretion [205].”
BackgroundThe Ryanodine Receptor Calcium Channel of β-Cells
Islam, M. S. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1299 · Cited by 120 · cited 1×
“RYR amplifies Ca2+ signals when the channel is sensitized by messenger molecules generated from the nutrient metabolism or ligand-binding and are involved in the amplification of insulin secretion [43] (Figure 1A).”
BackgroundTranscriptional Control of Apolipoprotein A-I Gene Expression in Diabetes
Mooradian, A. D., Haas, M. J., & Wong, N. C. W. (2004) · Diabetes · doi:10.2337/diabetes.53.3.513 · Cited by 119
Metabolic Memory Phenomenon and Accumulation of Peroxynitrite in Retinal Capillaries
Kowluru, R. A., Kanwar, M., & Kennedy, A. (2007) · Journal of Diabetes Research · doi:10.1155/2007/21976 · Cited by 115 · cited 1×
“The damage following hyperglycemia-induced oxidative stress can be prevented when good glycemic control is initiated very early, but is not easily reversed if poor control is maintained for a longer duration [108,109].”
BackgroundAbnormal hepatic apolipoprotein B metabolism in type 2 diabetes
Vergès, B. L. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.01.028 · Cited by 115
Dabelea (2009) · doi:10.2337/dc09-s206 · Cited by 115
Endocrinology: An Integrated Approach
Nussey, S., & Whitehead, S. (2001) · Taylor & Francis eBooks · doi:10.4324/9780203450437 · Cited by 114
Diabetes, advanced glycation endproducts and vascular disease
Wautier, J.-L., & Guillausseau, P.-J. (1998) · Vascular Medicine · doi:10.1177/1358836x9800300207 · Cited by 113 · cited 1×
“This leads to a pro-coagulant state in the surface of the endothelium and increases growth factor production resulting in a thickening of the basement membrane, thus favoring protein and lipid deposition and impairing vasodilation [242,246].”
BackgroundReversal of hyperglycemia and diabetic nephropathy
Kowluru, R. A., Abbas, S. N., & Odenbach, S. (2004) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2004.03.002 · Cited by 112
Laatsch, A., Merkel, M., Talmud, P. J., Grewal, T., Beisiegel†, U., & Heeren, J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.046 · Cited by 111 · cited 13×
“These events result in the accumulation of VLDL remnants and IDL due to diminished clearance of TRLs by hepatocytes [210].”
BackgroundInfluentialChan, J. C. N., Cheung, C. K., Swaminathan, R., Nicholls, M. G., & Cockram, C. S. (1993) · Postgraduate Medical Journal · doi:10.1136/pgmj.69.809.204 · Cited by 109
Ofori, J. K., Salunkhe, V. A., Bagge, A., Vishnu, N., Nagao, M., Mulder, H., Wollheim, C. B., Eliasson, L., & Esguerra, J. L. S. (2017) · Scientific Reports · doi:10.1038/srep44986 · Cited by 107 · cited 1×
“1), and multiple miRNAs have been shown to be involved in the pathogenesis of T2DM, including miR-200, miR-7, miR-184, miR-212/miR132 and miR-130a/b/miR-152 [94].”
BackgroundIncreased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
Kanter, J. E., Shao, B., Kramer, F., Barnhart, S., Shimizu-Albergine, M., Vaisar, T., Graham, M. J., Crooke, R. M., Manuel, C. R., Haeusler, R. A., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127308 · Cited by 105 · cited 1×
“As mentioned above, in the IR milieu, insulin has reduced capacity to inhibit VLDL secretion in the fed state, the availability of apo-CII is lower and apo-CIII production is increased [209].”
BackgroundEndoplasmic reticulum stress alters ryanodine receptor function in the murine pancreatic β cell
Yamamoto, W. R., Bone, R. N., Sohn, P., Syed, F., Reissaus, C. A., Mosley, A. L., Wijeratne, A. B., True, J. D., Tong, X., Kono, T., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005683 · Cited by 96
Chung, S., Sawyer, J. K., Gebre, A. K., Maeda, N., & Parks, J. S. (2011) · Circulation · doi:10.1161/circulationaha.111.025445 · Cited by 95
Battisti, W. P., Palmisano, J. J., & Keane, W. F. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.181 · Cited by 94 · cited 1×
“Dyslipidae ia is a co on feature of T2DM, and increases the incidence of atherosclerosis and mortality of diabetic patients [186].”
BackgroundMolecular Mechanisms Linking Diabetes to the Accelerated Development of Atherosclerosis
Zeadin, M. G., Petlura, C., & Werstuck, G. H. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.06.001 · Cited by 91
Choi, S. H., Kwak, S. H., Lee, Y., Moon, M. K., Lim, S., Park, Y. J., Jang, H. C., & Kim, M. S. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04095.x · Cited by 90 · cited 1×
“High vaspin is also associated with increased severity of coronary artery disease [286].”
BackgroundTriglyceride-rich lipoproteins and remnants: targets for therapy?
Dallinga-Thie, G. M., Kroon, J., Borén, J., & Chapman, M. J. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0745-6 · Cited by 90
Li, G. D., Milani, D., Dunne, M. J., Pralong, W. F., Theler, J. M., Petersen, O. H., & Wollheim, C. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67816-6 · Cited by 85 · cited 1×
“In the case of P2Y receptors, it has been proposed that insulin release could be mediated by intracellular Ca2+ mobilization in response to inositol-1,4,5-trisphosphate (IP3) formation that triggers the release of Ca2+ from ER stores, which amplifies the exocytosis-triggering Ca2+ signal [48,49] (Figure 1A).”
BackgroundLin, H.-Y., Weng, S.-W., Chang, Y.-H., Su, Y.-J., Chang, C.-M., Tsai, C.-J., Shen, F.-C., Chuang, J.-H., Lin, T.-K., Liou, C.-W., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7514383 · Cited by 85 · cited 1×
“Furthermore, increased mitochondrial fission and mitochondrial fragmentation have been associated with mitochondrial depolarization, impaired ATP production and decreased insulin-dependent glucose uptake as well as increased mitochondrial ROS and impaired insulin signalling in C2C12 murine cell line and cybrids, respe…”
BackgroundBlomen, V. A., & Boonstra, J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0505-5 · Cited by 84
Characterisation of a recombinant P2Y purinoceptor
Simon, J., Webb, T. E., King, B. F., Burnstock, G., & Barnard, E. A. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)90068-3 · Cited by 84 · cited 1×
“P2Y purinoreceptors have been reported to be coupled to G-proteins [45,46] whereas P2X-type receptors are ATP-activated ligand-gated ion channels non-selective for cations [47].”
BackgroundProinsulin processing in the regulated and the constitutive secretory pathway
Halban, P. A. (1994) · Diabetologia · doi:10.1007/bf00400828 · Cited by 82 · cited 1×
“Afterwards, proinsulin is translocated from the ER to the Golgi apparatus (GA), entering into immature secretory vesicles and being cleaved into C-peptide and insulin [38,39].”
BackgroundAdipokines and the cardiovascular system: mechanisms mediating health and disease
Northcott, J. M., Yeganeh, A., Taylor, C. G., Zahradka, P. C., & Wigle, J. T. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-053 · Cited by 81
Lipoproteins and the pathogenesis of atherosclerosis.
Steinberg, D., Carew, T. E., Fielding, C., Fogelman, A. M., Mahley, R. W., Sniderman, A. D., & Zilversmit, D. B. (1989) · Circulation · doi:10.1161/01.cir.80.3.719 · Cited by 80
Graciano, M. F. R., Valle, M. M. R., Kowluru, A., Curi, R., & Carpinelli, Â. R. (2011) · Islets · doi:10.4161/isl.3.5.15935 · Cited by 79 · cited 1×
“Additionally, increased blood levels of FFAs also lead to mitochondrial dysfunction through two different mechanisms: (1) FFA metabolism by-products disturb the electron flow throughout the mitochondrial respiratory chain and (2) through the incorporation of FFAs into the mitochondrial membranes, thus likely favoring…”
BackgroundAthyros, V. G., Tziomalos, K., Karagiannis, A., & Mikhailidis, D. P. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010024 · Cited by 76 · cited 1×
“Even when treated with statins, patients with the atherogenic dyslipidemia phenotype have a higher risk of CV events than those without AD [236,237].”
BackgroundNussey, S. S., & Whitehead, S. A. (2001) · CRC Press eBooks · doi:10.1201/b15306 · Cited by 75
Tawata, M., Hayashi, J. I., Isobe, K., Ohkubo, E., Ohtaka, M., Chen, J., Aida, K., & Onaya, T. (2000) · Diabetes · doi:10.2337/diabetes.49.7.1269 · Cited by 69
MicroRNAs in islet hormone secretion
Esguerra, J. L. S., Nagao, M., Ofori, J. K., Wendt, A., & Eliasson, L. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13382 · Cited by 69 · cited 2×
“Conversely, it is the downregulation of miR-375 expression that causes a reduction in β-cell mass [93,96,97].”
BackgroundElsaid, N. H., Sadik, N. A., Ramadan, N., Fayez, S. E., & Mohamed, N. (2018) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2018.05.003 · Cited by 68 · cited 1×
“In humans, an inverse correlation between omentin levels and IR is seen, both at the protein and mRNA levels [277,279,280].”
BackgroundVon Willebrand factor in diabetic angiopathy.
Kessler, L., Wiesel, M. L., Attali, P., Mossard, J. M., Cazenave, J., & Pinget, M. (1998) · PubMed · Cited by 66
Is Hyperglycemia a Causal Factor in Cardiovascular Disease?
Davidson, J. A., & Parkin, C. G. (2009) · Diabetes Care · doi:10.2337/dc09-s333 · Cited by 65
Wang, J., Gao, Y., Lin, F., Han, K., & Wang, X. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108187 · Cited by 64 · cited 1×
“Additional studies show that omentin has anti-inflammatory properties, diminishes cytokine expression [281,282], and is negatively associated with systemic inflammatory markers such as TNF and IL-6 [283].”
BackgroundGut microbiome and the risk factors in central nervous system autoimmunity
Ochoa-Repáraz, J., & Kasper, L. H. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.09.024 · Cited by 62
Blachier, F., & Malaisse, W. J. (1988) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(88)90182-6 · Cited by 62 · cited 1×
“In the case of P2Y receptors, it has been proposed that insulin release could be mediated by intracellular Ca2+ mobilization in response to inositol-1,4,5-trisphosphate (IP3) formation that triggers the release of Ca2+ from ER stores, which amplifies the exocytosis-triggering Ca2+ signal [48,49] (Figure 1A).”
BackgroundInsulin secretion from beta cells within intact islets: Location matters
Do, O. H., & Thorn, P. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12368 · Cited by 60
Macrovascular angiopathy in children and adolescents with type 1 diabetes
Giannini, C., Mohn, A., Chiarelli, F., & Kelnar, C. J. H. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1195 · Cited by 60 · cited 10×
“In this condition, proinflammatory molecules are released into the bloodstream and within specific tissues such as interleukin 6 (IL-6), C-Reactive Protein (CRP), tumor necrosis factor-alpha (TNF-α) or IL-1 induces an inflammatory state known as metabolic inflammation [37].”
BackgroundInfluentialEpigenetic changes in diabetes
Al-Haddad, R., Karnib, N., Assaad, R. A., Bilen, Y., Emmanuel, N., Ghanem, A., Younes, J., Zibara, V., Stephan, J. S., & Sleiman, S. F. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.046 · Cited by 58
Approach to diabetes management in patients with CVD
Lathief, S., & Inzucchi, S. E. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.05.005 · Cited by 56 · cited 1×
“Atherosclerosis is accelerated by the increased permeability of sdLDL into the subendothelial space (Figure 7) [221,222].”
BackgroundDoes Exercise Without Weight Loss Improve Insulin Sensitivity?
Ross, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.944 · Cited by 56
Adiponectin-Mediated Antilipotoxic Effects in Regenerating Pancreatic Islets
Ye, R., Wang, M., Wang, Q. A., & Scherer, P. E. (2015) · Endocrinology · doi:10.1210/en.2015-1066 · Cited by 56 · cited 1×
“In addition, adiponectin ameliorates β-cell death by neutralizing inflammatory and lipotoxic ceramides and DAGs [264] and shows strong anti-inflammatory effects on other cell types such as macrophages and fibrogenic cells [263,265,266].”
Background[Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
Cai, R.-C., Li, W., Di, J., Yu, H.-Y., Bao, Y.-Q., & Jia, W. (2009) · PubMed · Cited by 54
Nod-Like Receptor Protein 1 Inflammasome Mediates Neuron Injury under High Glucose
Meng, X., Wang, X., Tian, X., Yang, Z., Chu, G., Zhang, J., Li, M., Shi, J. C., & Zhang, C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8551-2 · Cited by 54
Wang, D., Taniyama, M., Suzuki, Y. A., Katagiri, T., & Ban, Y. (2001) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2001-17407 · Cited by 51
El-Lebedy, D. H., Ibrahim, A. A., & Ashmawy, I. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.04.025 · Cited by 50 · cited 1×
“6 times increased risk of CVD incidence in T2DM patients [70].”
BackgroundNew Mitochondrial DNA Homoplasmic Mutations Associated With Japanese Patients With Type 2 Diabetes
Tawata, M., Ohtaka, M., Iwase, E., Ikegishi, Y., Aida, K., & Onaya, T. (1998) · Diabetes · doi:10.2337/diab.47.2.276 · Cited by 49
Gæde, P., Jepsen, P. V., Larsen, J. N. B., Jensen, G. V. H., Parving, H., & Pedersen, O. B. (2003) · PubMed · Cited by 49
Tang, D., Zhou, X. H., Li, X., Жао, Л., & Liu, F. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.12.001 · Cited by 48
Adipose Modulation of High-Density Lipoprotein Cholesterol
McGillicuddy, F. C., Reilly, M. P., & Rader, D. J. (2011) · Circulation · doi:10.1161/circulationaha.111.058453 · Cited by 45
Insulin action on the liver in vivo
Cherrington, A. D., Moore, M. C., Sindelar, D. K., & Edgerton, D. S. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351171 · Cited by 43 · cited 2×
“While glucagon induces hepatic glucose production, insulin acts as a potent inhibitor of glucose production when its concentration in the blood is elevated [170].”
BackgroundCellular mechanism of insulin resistance in skeletal muscle.
Petersen, K. F., & Shulman, G. I. (2002) · Europe PMC (PubMed Central) · Cited by 41
Validation of Insulin Sensitivity and Secretion Indices Derived from the Liquid Meal Tolerance Test
Maki, K. C., Kelley, K., Lawless, A. L., Hubacher, R., Schild, A. L., Dicklin, M. R., & Rains, T. M. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0240 · Cited by 40 · cited 2×
“considered to be a key part in the pathogenesis of IR and T2DM [168].”
BackgroundFocusing on mitochondrial form and function
(2018) · Nature Cell Biology · doi:10.1038/s41556-018-0139-7 · Cited by 39
Pearson, T., Wattis, J. A. D., King, J. R., MacDonald, I. A., & Mazzatti, D. J. (2016) · Bulletin of Mathematical Biology · doi:10.1007/s11538-016-0181-1 · Cited by 37 · cited 1×
“There are three broad categories of IR or insulin-deficient conditions: (1) diminished insulin secretion by β-cells; (2) insulin antagonists in the plasma, due either to counter-regulatory hormones or non-hormonal bodies that impair insulin receptors or signaling; and (3) impaired insulin response in target tissues [1…”
BackgroundModulatory Role of Omentin-1 in Inflammation: Cytokines and Dietary Intake
Zabetian-Targhi, F., Mirzaei, K., Keshavarz, S. A., & Hossein-Nezhad, A. (2016) · Journal of the American College of Nutrition · doi:10.1080/07315724.2015.1126207 · Cited by 36
Association of Vaspin with Metabolic Syndrome: The Pivotal Role of Insulin Resistance
Esteghamati, A., Noshad, S., Mousavizadeh, M., Zandieh, A., & Nakhjavani, M. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.2.143 · Cited by 33 · cited 1×
“Vaspin (visceral adipose tissue-derived serine protease inhibitor) is an adipokine that inhibits proteases responsible for IR and protects against atherosclerosis and plaque development [284,285].”
BackgroundCuíñas, A., García‐Morales, V., Viña, D., Gil‐Longo, J., & Campos‐Toimil, M. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.03.059 · Cited by 31 · cited 1×
“Accumulated evidence suggests that cAMP induces insulin-containing secretory vesicle mobilization by depleting intracellular Ca2+ reservoirs, thereby increasing intracellular Ca2+ concentrations [44].”
BackgroundDullaart, R. P. F., Kappelle, P. J. W. H., & Dallinga‐Thie, G. M. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.03.024 · Cited by 30
Potential role of Toll-like receptors in programming of vascular dysfunction
Thompson, J. A., & Webb, R. C. (2013) · Clinical Science · doi:10.1042/cs20120673 · Cited by 29 · cited 1×
“Many environmental factors (age, obesity, sedentarism and diet) that promote T2DM development trigger an inflammatory response leading to IR and endothelial dysfunction [105,110,111].”
BackgroundZhou, H., Shiu, S. W. M., Wong, Y., & Tan, K. C. B. (2009) · Diabetes and Vascular Disease Research · doi:10.1177/1479164109344934 · Cited by 25 · cited 2×
“The impaired RCT activity has been associated with increased risk of CAD [219] and with flow-mediated vasodilation in T2DM patients [220].”
BackgroundFernández‐Trasancos, Á., Agra, R. M., García‐Acuña, J. M., Fernández, Á. L., González‐Juanatey, J. R., & Eiras, S. (2017) · Obesity · doi:10.1002/oby.21832 · Cited by 25 · cited 1×
“Additional studies show that omentin has anti-inflammatory properties, diminishes cytokine expression [281,282], and is negatively associated with systemic inflammatory markers such as TNF and IL-6 [283].”
BackgroundEzenwaka, C. E., & Kalloo, R. (2005) · PubMed · Cited by 11
Research works printed but not linked: 1
- Simmons, 2008, Epigenetic Influences and Disease, Nat. Educ., 1, 6
Cited by
Redox metabolism: ROS as specific molecular regulators of cell signaling and function
Lennicke, C., & Cochemé, H. M. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.018 · Cited by 1,246
Pathophysiology of Atherosclerosis
Jebari-Benslaiman, S., Galicia-García, U., Larrea-Sebal, A., Olaetxea, J. R., Alloza, I., Vandenbroeck, K., Benito-Vicente, A., & Martín, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063346 · Cited by 1,010
Self-citationAntar, S. A., Ashour, N. A., Sharaky, M., Khattab, M., Ashour, N. A., Zaid, R. T., Roh, E. J., Elkamhawy, A., & Al-Karmalawy, A. A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115734 · Cited by 622
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Wearable Electrochemical Glucose Sensors in Diabetes Management: A Comprehensive Review
Saha, T., Del Caño, R., Mahato, K., De la Paz, E., Chen, C., Ding, S., Yin, L., & Wang, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00078 · Cited by 442
Metadata
- Authors
- Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C.
- Affiliations
- Fundación Biofisika Bizkaia, Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Harvard University (US)
- CIC biomaGUNE (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-08-30
- Volume
- 21
- Issue
- 17
- Pages
- 6275
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7503727
- OpenAlex
- W3081655479
- Cited by
- 3,360
- References
- 297
- Citations by year
- 2026: 627 · 2025: 783 · 2024: 812 · 2023: 646 · 2022: 379 · 2021: 100 · 2020: 7
- FWCI
- 64.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Communities in ADDI (University of the Basque Country) (submittedVersion, other-oa)
- Communities in ADDI (Universidad del Pais Vasco) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Hispana (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, pancreatic beta cells, insulin biosynthesis, insulin signaling, glucose homeostasis, gut dysbiosis, metabolic memory, nutrition, physical activity, atherosclerosis, cardiovascular risk
- MeSH terms
- Insulin Secretion, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Homeostasis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.